5/8/98
Scab folk: The following is a note I wrote to send to Olin Anderson. I'm sending it to you as food for thought. Responses (especially on the LISTSERVER) are welcomed and desired. Background: Scientists at ARS at Peoria (including Tom Hohn) have cloned a Fusarium gene they call TRIr. My understanding is that it codes for an enzyme that acetlyates DON, thus rendering it nontoxic. There is reason to believe (but not proof) that a plant producing this enzyme could exhibit some level of resistance to scab. The gene was made available earlier this year and is already a target gene for transformation into barley and wheat (at ARS labs). PDR5 is a gene that codes for a molecular pump that removes DON from cells.
Hello Olin- Thanks much for the biotech proposal. Tom Hohn was here yesterday. The tantalizing possibility that the TRIr gene that detoxifies DON could impart economically useful resistance to scab is clearly of great importance. I believe TRIr (and PDR5) represent a tremendous opportunity and challenge for the national scab initiative. Tom told me you and Lynne in ND are working with Tom to create transgenic wheat and barley carrying those genes. The utility of those genes in wheat or barley remains to be proven. But imagine for a moment that the wheat/barley-targeted engineered versions of TRIr you are now working with (or PDR5 or anything else)do in fact prove useful and warrant inclusion in cultivars. That proof is several years away. If we wait for confirmation to initiate plant breeding efforts to deploy those constructs, we will have lost several years [because we could start deployment now]. If we start deploying them now and they prove inadequate, we will have wasted the breeding resources involved. This represents two 'errors' or loss scenarios- 1) We are cautious and await proof of function, and start deployment three?? years after the gene was available 2) We proceed with deployment only to learn that the gene fails to meet our needs.
To me, the second kind of error is miniscule in cost compared to the first. The ideal of course is that the gene(s) work and we launch deployment now. I believe that the growers and processors supporting our efforts would expect us to launch deployment immediately with any gene that has a real chance of working. Each year of delay beyond the absolute minimum time required to get a useful gene into farmers fields potentially represents many millions of dollars and social costs that are arguably unnecessary losses.
Time to deployment of a gene (engineered, or from natural genes) into farmers fields depends on 1) when deployment is initiated, and 2) how long it takes to get the gene into an acceptable genotype with seed quantities adequate to meet the grower's needs. I've focused on point 1 here, and am advocating the extreme position that we should launch deployment NOW. But exactly how would the step 2 take place? Transform all elite varieties? Through sexual hybridization and conventional breeding? Should the latter be facilitated by simple detection systems for the gene itself (ELISA, PCR?), and should well distributed and highly polymorphic markers be used to accelerate the rate of discarding the unwanted genome segments from the donor genotype? I think large seed companies are deploying Bt and herbicide resistance genes from a small set (or even 1) initial transformants through breeding rather than by transforming each seed parent independently (if someone has supporting or contradictory knowledge of this, I would grateful to hear from you).
Deployment can proceed ad hoc on the basis of each breeder or institute or company acquiring the gene, or partnering with someone who already has the gene, or ..... That is not, I believe, what the supporters of the scab initiative want to have happen, nor do I think it is the best we can do. Instead, we should be constructing a lab to farm gene deployment system that ensures that all genes of value are farm-deployed as early as physically possible. The optimal gene deployment system(s) depends on available human, physical, and financial resources and can only be designed and implemented by focused engagement by all players from the lab to the seed producer.
I see the newly available TRIr gene as an opportunity to facilitate maturation of the genetic part of the initiative into a fine-tuned deployment system. I propose we declare TRIr (and other transgenes??) a target for development and testing of a gene deployment system. In some sense I'm suggesting a 'war game' where we assume TRIr is a useful gene. It may turn out to be a dry-run, but we will have addressed in a real world manner the logistical and organizational hurdles that are difficult to imagine, let alone conquer. (and of course if TRIr works, not an entirely unlikely scenario, we will have achieved our goal of enhancement of in-farm resistance levels in the shortest period of time possible).
The system we develop will of course have utility with any new candidate transgenes. It will also have utility in deployment of genes discovered in wheat, barley, or their relatives. In short, the resulting gene deployment system is exactly what the genetic component of the scab initiative is all about.
I have no doubt that the major seed companies and perhaps even some of the state systems are already engaged in resolution of deployment systems for candidate genes like TRIr. That is good and expected. The scab initiative needs to follow the same course. Without a 'hot' target like TRIr, I'm worried we'll not gain the momentum and focus needed to move ourselves forward. We'll be talking about getting organized rather than doing it. If we wait for a proven gene to appear (and we must assume that useful genes will be found), we will have unnecessarily lost time in getting organized. If we seize upon this opportunity with vigor we will reward our supporters with the action they want- and that will enhance their willingness to ask congress for financial support.
Rick Ward
Associate Professor/Wheat Breeder Michigan State University wardri@pilot.msu.edu (517)-355-2231(land) (517)-285-9725 (cell) (517)-353-3955 (fax) address: MSU/Dept of CSS 382 PSSB East Lansing MI 48824 USA